Product
Information
Generic Name: Lenvatinib (besylate)
Indications
•
Hepatocellular carcinoma.
•
Radioiodine-refractory differentiated thyroid carcinoma.
•
Advanced renal cell carcinoma (in combination therapy).
•
Advanced endometrial carcinoma (in combination with
pembrolizumab).
Strength: 4 mg and 10 mg
Pack Size: Blister pack - 30 capsules
Dosage Form: Capsule
Categories: Pharmaceuticals
Therapeutic Class: Tyrosine Kinase Inhibitor
At Amgomed, we recognize that robust business relationships are pivotal in delivering superior healthcare solutions. As an established entity in the pharmaceutical industry, we have cultivated enduring partnerships with global manufacturers to introduce innovative oncology products to patients across Pakistan.
